Skip to main content
. 2020 Jun 6;148(3):577–585. doi: 10.1007/s11060-020-03551-3

Table 2.

Radiation parameters

Patient number Location GTV CTV margin (cm) PTV margin (cm) PTV volume (cm3) Type Number of fractions planned Total dose planned (cGy) Number of fractions delivered Completed radiation
1 Enhancing 2 + FLAIR 0.3 667 IMRT 15 3750 15 Y
2 FLAIR + enhancing 0.5 0.3 487 IMRT 20 4000 20 Y
3 Enhancing 2.5 + FLAIR 0.3 398 IMRT 20 4000 20 Y
4 FLAIR + enhancing 1 0.3 398 IMRT 15 3750 15 Y
5 FLAIR + enhancing 1 0.3 397 IMRT 20 4000 13 N
6 Enhancing 1 0.3 195 IMRT 15 3750 15 Y
7 FLAIR + enhancing 0 0.5 225 IMRT 15 3750 15 Y
8 FLAIR + enhancing 0 0.5 145 IMRT 20 4000 20 Y
9 Enhancing mass 0.5 0 36 IMRT 15 3750 15 Y
10 Enhancing 0.5 0.3 190 IMRT 15 3750 15 Y
11 FLAIR + enhancing 1 0.3 442 VMAT 15 3750 15 Y
12 Enhancing 0 0.3 148 IMRT 10 3500 10 Y
13 Enhancing 0 0.3 181 VMAT 15 3750 15 Y
14 Enhancing 1 0.3 245 IMRT 22 4400 22 Y
15 FLAIR + enhancing 0 0.3 394 IMRT 15 3750 5 N
16 FLAIR + enhancing 0 0.3 216 IMRT 15 3750 15 Y
17 FLAIR + enhancing 1 0.7 443 VMAT 30 5400 5 N
18 FLAIR + enhancing 0 0.3 81.4 IMRT 15 3750 15 Y
19 FLAIR + enhancing 0 0.3 100 VMAT 15 3750 15 Y
20 FLAIR + enhancing 0 0.3 118 VMAT 15 3750 2 N
21* Splenium FLAIR + enhancing 0 0.3 34 VMAT 14 3500 9 N
21 Brachium pontis FLAIR + enhancing 0 0.1 0.3 SRS 5 2000 2 N
22 Enhancing 0.5 0.3 112 VMAT 15 3750 15 Y

KEY: IMRT static field intensity modulated radiation therapy, VMAT volumetric modulated arc therapy, SRS stereotactic radiosurgery, FLAIR fluid attenuation inversion recovery

*Patient 21 had two separate lesions radiated in two discontiguous fields on trial. All other patients had one contiguous radiation field